tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

bioAffinity Technologies Inc

BIAF
Add to Watchlist
0.638USD
-0.006-0.95%
Close 07-31 16:00（ET）Quotes delayed by 15 min
2.21MMarket Cap
LossP/E TTM

bioAffinity Technologies Inc

0.638
-0.006-0.95%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

BIAF Financials

See bioAffinity Technologies Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

bioAffinity Technologies Inc Earnings Date

Latest Release
May 8, 2026
EPS / Forecast
-0.81/-2.40
Revenue / Forecast
1.35M/1.48M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
6.16M
-34.18%
EPS(YoY)
-8.66
61.27%
Analyst Rating
HOLD
2025/12/09
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q2
FY2021Q1
Financial Indicators
EPS
-393.61%-0.81
-249.80%-0.70
-2833.73%-4.74
8.76%-0.17
17.29%-0.16
21.07%-0.20
38.71%-0.16
9.27%-0.19
-8.86%-0.20
31.71%-0.25
---0.26
---0.20
---0.18
---0.37
---0.77
----
----
----
----
Revenue
-27.09%1.35M
-27.85%1.59M
-38.48%1.45M
-47.05%1.27M
-22.97%1.85M
-0.26%2.21M
687.44%2.35M
12047.39%2.40M
261180.24%2.41M
94245.95%2.21M
25855.13%298.48K
1411.33%19.74K
--921.00
--2.35K
--1.15K
--1.31K
----
----
----
Net Profit
-36.47%-3.63M
-5.75%-3.14M
-152.45%-5.05M
-92.43%-4.06M
-35.61%-2.66M
-25.02%-2.97M
12.66%-2.00M
-21.27%-2.11M
-27.99%-1.96M
-41.72%-2.37M
53.43%-2.29M
-1876.30%-1.74M
-4.13%-1.53M
---1.67M
---4.92M
-105.95%-88.05K
-105.54%-1.47M
--1.48M
---716.18K
Net Margin
-87.16%-268.63%
-46.57%-196.98%
-310.32%-349.30%
-263.44%-319.88%
-76.05%-143.53%
-25.34%-134.40%
88.91%-85.13%
99.00%-88.01%
99.95%-81.53%
99.85%-107.22%
---767.51%
---8816.36%
---166426.71%
---71380.35%
---263717.13%
----
----
----
----
Gross Margin
27.72%22.82%
60.36%35.72%
-16.37%27.00%
-68.56%11.00%
-37.08%17.87%
23.36%22.28%
-42.01%32.29%
-62.68%34.99%
-68.64%28.40%
-80.49%18.06%
--55.69%
--93.75%
--90.55%
--92.54%
--88.12%
----
----
----
----
Debt to assets ratio
-45.62%8.75%
-52.84%7.47%
-85.77%2.65%
-64.91%5.53%
13.59%16.09%
8.42%15.84%
47.27%18.61%
3202.30%15.75%
779.92%14.16%
606.85%14.61%
--12.64%
--0.48%
--1.61%
--2.07%
--5.80%
----
----
----
----
Income Statement
Revenue
-27.09%1.35M
-27.85%1.59M
-38.48%1.45M
-47.05%1.27M
-22.97%1.85M
-0.26%2.21M
687.44%2.35M
12047.39%2.40M
261180.24%2.41M
94245.95%2.21M
25855.13%298.48K
1411.33%19.74K
--921.00
--2.35K
--1.15K
--1.31K
----
----
----
Operating profit
-37.68%-3.62M
-6.46%-3.14M
-16.16%-2.29M
-20.49%-2.52M
-35.06%-2.63M
-25.79%-2.95M
13.97%-1.97M
-17.40%-2.09M
-24.86%-1.95M
-44.26%-2.34M
-135.06%-2.29M
-159.95%-1.78M
-114.29%-1.56M
---1.62M
---976.16K
-29.18%-684.12K
-48.01%-727.04K
---529.57K
---491.21K
Net Profit
-36.47%-3.63M
-5.75%-3.14M
-152.45%-5.05M
-92.43%-4.06M
-35.61%-2.66M
-25.02%-2.97M
12.66%-2.00M
-21.27%-2.11M
-27.99%-1.96M
-41.72%-2.37M
53.43%-2.29M
-1876.30%-1.74M
-4.13%-1.53M
---1.67M
---4.92M
-105.95%-88.05K
-105.54%-1.47M
--1.48M
---716.18K
Balance Sheet
Current assets
132.94%4.34M
180.70%7.57M
237.90%8.61M
-37.74%1.67M
-52.59%1.86M
-32.16%2.70M
-57.59%2.55M
-69.05%2.68M
-61.58%3.93M
-66.79%3.97M
-57.24%6.01M
2546.08%8.66M
825.51%10.23M
--11.96M
--14.05M
--327.25K
--1.11M
----
----
Total current liabilities
-6.75%3.18M
-6.40%2.91M
-5.28%2.36M
11.26%2.59M
92.79%3.42M
38.13%3.10M
27.19%2.49M
200.11%2.33M
122.48%1.77M
97.41%2.25M
33.77%1.96M
-94.33%775.15K
-94.26%796.30K
--1.14M
--1.46M
--13.68M
--13.88M
----
----
Total assets
43.23%7.95M
68.27%10.96M
76.23%11.55M
-28.62%4.75M
-31.08%5.55M
-20.77%6.51M
-35.70%6.55M
-24.99%6.66M
-23.08%8.05M
-32.51%8.22M
-27.54%10.19M
843.24%8.87M
673.43%10.46M
--12.18M
--14.06M
--940.75K
--1.35M
----
----
Total liabilities
4.28%4.28M
-5.84%3.68M
-22.93%2.64M
113.67%6.89M
47.12%4.11M
16.20%3.91M
7.37%3.43M
315.83%3.22M
250.65%2.79M
195.63%3.37M
118.25%3.20M
-94.33%775.15K
-94.33%796.30K
--1.14M
--1.46M
--13.68M
--14.03M
----
----
Total equity
154.37%3.66M
179.69%7.28M
185.23%8.90M
-162.22%-2.14M
-72.62%1.44M
-46.41%2.60M
-55.38%3.12M
-57.61%3.43M
-45.63%5.26M
-56.03%4.86M
-44.49%6.99M
163.56%8.10M
176.25%9.67M
--11.04M
--12.60M
---12.74M
---12.68M
----
----
Cash Flow Statement
Net operating income
-96.57%-3.23M
-52.61%-2.56M
-45.11%-2.48M
-72.75%-2.65M
30.02%-1.64M
-3.77%-1.68M
-11.53%-1.71M
-12.68%-1.53M
-53.43%-2.35M
-24.27%-1.62M
12.93%-1.53M
-261.55%-1.36M
-141.19%-1.53M
---1.30M
---1.76M
-3.72%-376.14K
-61.50%-633.97K
---362.66K
---392.55K
Net investment
88.85%-5.66K
0.00%-1.00
138.75%3.65K
52.53%-13.43K
-22.71%-50.79K
-100.01%-1.00
99.57%-9.41K
-632.58%-28.29K
-28.08%-41.39K
106.11%13.44K
---2.19M
---3.86K
---32.31K
---219.99K
----
----
----
----
----
Net financing
-111.48%-118.51K
-33.85%1.34M
458.15%9.34M
3412.08%3.02M
-48.89%1.03M
2488.86%2.03M
3397.25%1.67M
27.72%-91.14K
2523.25%2.02M
84.95%-84.81K
-100.34%-50.77K
71.18%-126.10K
-127.65%-83.32K
---563.56K
--15.04M
-167.31%-437.49K
-43.91%301.36K
--650.00K
--537.26K

FAQs

What is the total revenue of bioAffinity Technologies Inc?

According to bioAffinity Technologies Inc's FY2025 earnings report, its total revenue reached 6.16M, with a year-on-year change of 9.36M.

What are the current assets of bioAffinity Technologies Inc?

According to bioAffinity Technologies Inc's FY2025 earnings report, its current assets were 7.57M, with a year-on-year change of 180.70.

What are the total assets of bioAffinity Technologies Inc?

According to bioAffinity Technologies Inc's FY2025 earnings report, its total assets of bioAffinity Technologies Inc were 10.96M, with a year-on-year change of 68.27.

What are the total liabilities of bioAffinity Technologies Inc?

According to bioAffinity Technologies Inc's FY2025 earnings report, its total liabilities of bioAffinity Technologies Inc were 3.68M, with a year-on-year change of -5.84.

What is the total equity of bioAffinity Technologies Inc?

According to bioAffinity Technologies Inc's FY2025 earnings report, its total equity of bioAffinity Technologies Inc was 7.28M, with a year-on-year change of 179.69.

What is the net operating income of bioAffinity Technologies Inc?

According to bioAffinity Technologies Inc's FY2025 earnings report, its net operating income of bioAffinity Technologies Inc was -10.57M, with a year-on-year change of -18.08.

What is the net investment of bioAffinity Technologies Inc?

According to bioAffinity Technologies Inc's FY2025 earnings report, its net investment of bioAffinity Technologies Inc was -60.57K, with a year-on-year change of 23.41.

What is the net financing of bioAffinity Technologies Inc?

According to bioAffinity Technologies Inc's FY2025 earnings report, its net financing of bioAffinity Technologies Inc was 14.73M, with a year-on-year change of 161.82.

What is the Earnings Per Share (EPS) of bioAffinity Technologies Inc?

According to bioAffinity Technologies Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -8.66, with a year-on-year change of 61.27.

What is the net income of bioAffinity Technologies Inc?

According to bioAffinity Technologies Inc's FY2025 earnings report, its net income was -14.91M, with a year-on-year change of -64.93.

What is the net margin of bioAffinity Technologies Inc?

According to bioAffinity Technologies Inc's FY2025 earnings report, its net profit margin was -241.96, with a year-on-year change of -150.59.

What is the gross margin of bioAffinity Technologies Inc?

According to bioAffinity Technologies Inc's FY2025 earnings report, its gross margin was 23.21, with a year-on-year change of -21.63.

What is the debt-to-asset ratio of bioAffinity Technologies Inc?

According to bioAffinity Technologies Inc's FY2025 earnings report, its debt-to-asset ratio was 7.47, with a year-on-year change of -52.84.

What is the Return on Equity (ROE) of bioAffinity Technologies Inc?

According to bioAffinity Technologies Inc's FY2025 earnings report, its Return on Equity (ROE) was -301.83, with a year-on-year change of -24.49.

What is the Return on Assets (ROA) of bioAffinity Technologies Inc?

According to bioAffinity Technologies Inc's FY2025 earnings report, its Return on Assets (ROA) was -170.65, with a year-on-year change of -39.08.

What is the operating profit of bioAffinity Technologies Inc?

According to bioAffinity Technologies Inc's FY2025 earnings report, its operating profit was -10.57M, with a year-on-year change of -18.08.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy